269 related articles for article (PubMed ID: 31923197)
1. Association between opioid analgesic therapy and initiation of buprenorphine management: An analysis of prescription drug monitoring program data.
Alexandridis AA; Dasgupta N; Ringwalt CL; Rosamond WD; Chelminski PR; Marshall SW
PLoS One; 2020; 15(1):e0227350. PubMed ID: 31923197
[TBL] [Abstract][Full Text] [Related]
2. Adherence to buprenorphine: An analysis of prescription drug monitoring program data.
Pizzicato LN; Hom JK; Sun M; Johnson CC; Viner KM
Drug Alcohol Depend; 2020 Nov; 216():108317. PubMed ID: 33035714
[TBL] [Abstract][Full Text] [Related]
3. Associations between prescribed benzodiazepines, overdose death and buprenorphine discontinuation among people receiving buprenorphine.
Park TW; Larochelle MR; Saitz R; Wang N; Bernson D; Walley AY
Addiction; 2020 May; 115(5):924-932. PubMed ID: 31916306
[TBL] [Abstract][Full Text] [Related]
4. Benzodiazepine use during buprenorphine treatment for opioid dependence: clinical and safety outcomes.
Schuman-Olivier Z; Hoeppner BB; Weiss RD; Borodovsky J; Shaffer HJ; Albanese MJ
Drug Alcohol Depend; 2013 Oct; 132(3):580-6. PubMed ID: 23688843
[TBL] [Abstract][Full Text] [Related]
5. A predictive risk model for nonfatal opioid overdose in a statewide population of buprenorphine patients.
Chang HY; Krawczyk N; Schneider KE; Ferris L; Eisenberg M; Richards TM; Lyons BC; Jackson K; Weiner JP; Saloner B
Drug Alcohol Depend; 2019 Aug; 201():127-133. PubMed ID: 31207453
[TBL] [Abstract][Full Text] [Related]
6. Associations between implementation of Project Lazarus and opioid analgesic dispensing and buprenorphine utilization in North Carolina, 2009-2014.
Alexandridis AA; Dasgupta N; McCort AD; Ringwalt CL; Rosamond WD; Chelminski PR; Marshall SW
Inj Epidemiol; 2019 Jan; 6(1):2. PubMed ID: 30663005
[TBL] [Abstract][Full Text] [Related]
7. "Doctor and pharmacy shopping": A fading signal for prescription opioid use monitoring?
Delcher C; Harris DR; Park C; Strickler GK; Talbert J; Freeman PR
Drug Alcohol Depend; 2021 Apr; 221():108618. PubMed ID: 33677354
[TBL] [Abstract][Full Text] [Related]
8. Conversion of chronic pain patients from full-opioid agonists to sublingual buprenorphine.
Daitch J; Frey ME; Silver D; Mitnick C; Daitch D; Pergolizzi J
Pain Physician; 2012 Jul; 15(3 Suppl):ES59-66. PubMed ID: 22786462
[TBL] [Abstract][Full Text] [Related]
9. Shifting blame: Buprenorphine prescribers, addiction treatment, and prescription monitoring in middle-class America.
Mendoza S; Rivera-Cabrero AS; Hansen H
Transcult Psychiatry; 2016 Aug; 53(4):465-87. PubMed ID: 27488225
[TBL] [Abstract][Full Text] [Related]
10. The Prescription Opioid Addiction Treatment Study: What have we learned.
Weiss RD; Rao V
Drug Alcohol Depend; 2017 Apr; 173 Suppl 1(Suppl 1):S48-S54. PubMed ID: 28363320
[TBL] [Abstract][Full Text] [Related]
11. Mapping prescription drug monitoring program data to self-report measures of non-medical prescription opioid use in community pharmacy settings.
Charron E; Brooks JH; Peterson KT; Akinwolere OG; Winhusen T; Cochran G
Res Social Adm Pharm; 2023 Aug; 19(8):1171-1177. PubMed ID: 37142474
[TBL] [Abstract][Full Text] [Related]
12. Overlapping buprenorphine, opioid, and benzodiazepine prescriptions among veterans dually enrolled in Department of Veterans Affairs and Medicare Part D.
Gellad WF; Zhao X; Thorpe CT; Thorpe JM; Sileanu FE; Cashy JP; Mor M; Hale JA; Radomski T; Hausmann LR; Fine MJ; Good CB
Subst Abus; 2017; 38(1):22-25. PubMed ID: 27925868
[TBL] [Abstract][Full Text] [Related]
13. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
[TBL] [Abstract][Full Text] [Related]
14. Association of Buprenorphine-Waivered Physician Supply With Buprenorphine Treatment Use and Prescription Opioid Use in Medicaid Enrollees.
Wen H; Hockenberry JM; Pollack HA
JAMA Netw Open; 2018 Sep; 1(5):e182943. PubMed ID: 30646185
[TBL] [Abstract][Full Text] [Related]
15. Analysis of psychiatrists' prescription of opioid, benzodiazepine, and buprenorphine in Medicare Part D in the United States.
Pan K; Silver S; Davis C
Trends Psychiatry Psychother; 2020; 42(1):48-54. PubMed ID: 32321084
[TBL] [Abstract][Full Text] [Related]
16. Patterns of physician prescribing for opioid maintenance treatment in Ontario, Canada in 2014.
Guan Q; Khuu W; Spithoff S; Kiran T; Kahan M; Tadrous M; Martins D; Leece P; Gomes T
Drug Alcohol Depend; 2017 Aug; 177():315-321. PubMed ID: 28733101
[TBL] [Abstract][Full Text] [Related]
17. Association of Selected State Policies and Requirements for Buprenorphine Treatment With Per Capita Months of Treatment.
Stein BD; Saloner BK; Golan OK; Andraka-Christou B; Andrews CM; Dick AW; Davis CS; Sheng F; Gordon AJ
JAMA Health Forum; 2023 May; 4(5):e231102. PubMed ID: 37234015
[TBL] [Abstract][Full Text] [Related]
18. Prescribing patterns of buprenorphine waivered physicians.
Thomas CP; Doyle E; Kreiner PW; Jones CM; Dubenitz J; Horan A; Stein BD
Drug Alcohol Depend; 2017 Dec; 181():213-218. PubMed ID: 29096292
[TBL] [Abstract][Full Text] [Related]
19. Office-Based Buprenorphine Treatment: Identifying Factors That Promote Retention in Opioid-Dependent Patients.
Noe SR; Keller T
J Addict Nurs; 2020; 31(1):23-29. PubMed ID: 32132421
[TBL] [Abstract][Full Text] [Related]
20. Association Between Benzodiazepine or Z-Drug Prescriptions and Drug-Related Poisonings Among Patients Receiving Buprenorphine Maintenance: A Case-Crossover Analysis.
Xu KY; Borodovsky JT; Presnall N; Mintz CM; Hartz SM; Bierut LJ; Grucza RA
Am J Psychiatry; 2021 Jul; 178(7):651-659. PubMed ID: 33653119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
